Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study

by Carina Mihai, Rucsandra Dobrota, Shervin Assassi, Maureen D. Mayes, Oliver Distler
Published 2020-08-01

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?

by Victor Farutin, Elma Kurtagic, Joël R. Pradines, Ishan Capila, Maureen D. Mayes, Minghua Wu, Anthony M. Manning, Shervin Assassi
Published 2021-10-01

Right bundle branch block: a predictor of mortality in early systemic sclerosis.

by Hilda T Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B Gonzalez, Brock E Harper, Frank C Arnett, Ameena Manzoor, Richard A Lange, Maureen D Mayes
Published 2013-01-01

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis.

by Hilda T. Draeger, Shervin Assassi, Roozbeh Sharif, Emilio B. Gonzalez, Brock E. Harper, Frank C. Arnett, Ameena Manzoor, Richard A. Lange, Maureen D. Mayes
Published 2014-01-01

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis

by Bochra Jandali, Gloria A. Salazar, Marie Hudson, Marvin J. Fritzler, Marka A. Lyons, Rosa M. Estrada‐Y‐Martin, Julio Charles, Katherine A. Terracina, Maureen D. Mayes, Shervin Assassi
Published 2022-04-01

Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.

by Shervin Assassi, Astrud L Leyva, Maureen D Mayes, Roozbeh Sharif, Deepthi K Nair, Michael Fischbach, Ngan Nguyen, John D Reveille, Emilio B Gonzalez, Terry A McNearney, GENISOS Study Group
Published 2011-01-01

Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population.

by Jiucun Wang, Xinjian Guo, Lin Yi, Gang Guo, Wenzhen Tu, Wenyu Wu, Li Yang, Rong Xiao, Yuan Li, Haiyan Chu, Dongyi He, Li Jin, Maureen D Mayes, Hejian Zou, Xiaodong Zhou
Published 2014-01-01

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis

by Robyn T. Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W. Benton, Christa‐Lynn Vampola, Daniel E. Furst, Lorinda Chung, Virginia Steen, Maureen D. Mayes, Ami A. Shah, Jerry A. Molitor, Kelly Oliver, Vivek Nagaraja, Dinesh Khanna
Published 2023-03-01

Association of the HLA-DRB1 with scleroderma in Chinese population.

by Dongyi He, Jiucun Wang, Lin Yi, Xinjian Guo, Shicheng Guo, Gang Guo, Wenzhen Tu, Wenyu Wu, Li Yang, Rong Xiao, Yuan Li, Haiyan Chu, Syeling Lai, Li Jin, Hejian Zou, John D Reveille, Shervin Assassi, Maureen D Mayes, Xiaodong Zhou
Published 2014-01-01

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes

by Aimee L. Hanson, Aimee L. Hanson, Joanne Sahhar, Gene-Siew Ngian, Janet Roddy, Jennifer Walker, Wendy Stevens, Wendy Stevens, Mandana Nikpour, Mandana Nikpour, Shervin Assassi, Susanna Proudman, Susanna Proudman, Maureen D. Mayes, Tony J. Kenna, Matthew A. Brown, Matthew A. Brown
Published 2022-06-01

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND)

by Linda Kwakkenbos, Marie-Eve Carrier, Joep Welling, Kimberly A. Turner, Julie Cumin, Mia Pépin, Cornelia van den Ende, Anne A. Schouffoer, Marie Hudson, Ward van Breda, Maureen Sauve, Maureen D. Mayes, Vanessa L. Malcarne, Warren R. Nielson, Christelle Nguyen, Isabelle Boutron, François Rannou, Brett D. Thombs, Luc Mouthon, The SPIN Investigators
Published 2022-08-01

Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations

by Ana Márquez, Martin Kerick, Alexandra Zhernakova, Javier Gutierrez-Achury, Wei-Min Chen, Suna Onengut-Gumuscu, Isidoro González-Álvaro, Luis Rodriguez-Rodriguez, Raquel Rios-Fernández, Miguel A. González-Gay, Coeliac Disease Immunochip Consortium, Rheumatoid Arthritis Consortium International for Immunochip (RACI), International Scleroderma Group, Type 1 Diabetes Genetics Consortium, Maureen D. Mayes, Soumya Raychaudhuri, Stephen S. Rich, Cisca Wijmenga, Javier Martín
Published 2018-12-01

The Effect of Body Fat Distribution on Systemic Sclerosis

by Gonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, Elena López-Isac, Carmen P. Simeón, José L. Callejas, Shervin Assassi, Lorenzo Beretta, International SSc Group, Australian Scleroderma Interest Group (ASIG), Yannick Allanore, Susanna M. Proudman, Mandana Nikpour, Carmen Fonseca, Christopher P. Denton, Timothy R. D. J. Radstake, Maureen D. Mayes, Xia Jiang, Javier Martin, Lara Bossini-Castillo
Published 2022-10-01

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

by Franck F. Rahaghi, Vivien M. Hsu, Robert J. Kaner, Maureen D. Mayes, Ivan O. Rosas, Rajan Saggar, Virginia D. Steen, Mary E. Strek, Elana J. Bernstein, Nitin Bhatt, Flavia V. Castelino, Lorinda Chung, Robyn T. Domsic, Kevin R. Flaherty, Nishant Gupta, Bashar Kahaleh, Fernando J. Martinez, Lee E. Morrow, Teng Moua, Nina Patel, Oksana A. Shlobin, Brian D. Southern, Elizabeth R. Volkmann, Dinesh Khanna
Published 2023-01-01

47XXY and 47XXX in Scleroderma and Myositis

by R. Hal Scofield, Valerie M. Lewis, Joshua Cavitt, Biji T. Kurien, Shervin Assassi, Javier Martin, Olga Gorlova, Peter Gregersen, Annette Lee, Lisa G. Rider, Terrance O'Hanlon, Simon Rothwell, James Lilleker, Myositis Genetics Consortium, Xiaoxi Liu, Yuta Kochi, Chikacshi Terao, Ann Igoe, Wendy Stevens, Joanne Sahhar, Janet Roddy, Maureen Rischmueller, Sue Lester, Susanna Proudman, Sixia Chen, Matthew A. Brown, Maureen D. Mayes, Janine A. Lamb, Frederick W. Miller
Published 2022-06-01

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

by Martin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, José Luis Callejas, Shervin Assassi, International SSc Group, Susanna M. Proudman, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), PRECISESADS Clinical Consortium, Nicolas Hunzelmann, Gianluca Moroncini, Jeska K. de Vries-Bouwstra, Gisela Orozco, Anne Barton, Ariane L. Herrick, Chikashi Terao, Yannick Allanore, Carmen Fonseca, Marta Eugenia Alarcón-Riquelme, Timothy R. D. J. Radstake, Lorenzo Beretta, Christopher P. Denton, Maureen D. Mayes, Javier Martin
Published 2022-10-01

Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations.

by Olga Y Gorlova, Yafang Li, Ivan Gorlov, Jun Ying, Wei V Chen, Shervin Assassi, John D Reveille, Frank C Arnett, Xiaodong Zhou, Lara Bossini-Castillo, Elena Lopez-Isac, Marialbert Acosta-Herrera, Peter K Gregersen, Annette T Lee, Virginia D Steen, Barri J Fessler, Dinesh Khanna, Elena Schiopu, Richard M Silver, Jerry A Molitor, Daniel E Furst, Suzanne Kafaja, Robert W Simms, Robert A Lafyatis, Patricia Carreira, Carmen Pilar Simeon, Ivan Castellvi, Emma Beltran, Norberto Ortego, Christopher I Amos, Javier Martin, Maureen D Mayes
Published 2018-01-01

Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

by Linda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, Warren R. Nielson, Claire Fedoruk, Brooke Levis, Richard S. Henry, Janet Pope, Tracy Frech, Shadi Gholizadeh, Sindhu R. Johnson, Pamela Piotrowski, Lisa R. Jewett, Jessica Gordon, Lorinda Chung, Dan Bilsker, Lydia Tao, Kimberly A. Turner, Julie Cumin, Joep Welling, Catherine Fortuné, Catarina Leite, Karen Gottesman, Maureen Sauvé, Tatiana Sofia Rodriguez Reyna, Marie Hudson, Maggie Larche, Ward van Breda, Maria E. Suarez-Almazor, Susan J. Bartlett, Vanessa L. Malcarne, Maureen D. Mayes, Isabelle Boutron, Luc Mouthon, Andrea Benedetti, Brett D. Thombs, on behalf of the SPIN Investigators
Published 2022-02-01

The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial...

by Julia Nordlund, Richard S. Henry, Linda Kwakkenbos, Marie-Eve Carrier, Brooke Levis, Warren R. Nielson, Susan J. Bartlett, Laura Dyas, Lydia Tao, Claire Fedoruk, Karen Nielsen, Marie Hudson, Janet Pope, Tracy Frech, Shadi Gholizadeh, Sindhu R. Johnson, Pamela Piotrowski, Lisa R. Jewett, Jessica Gordon, Lorinda Chung, Dan Bilsker, Alexander W. Levis, Kimberly A. Turner, Julie Cumin, Joep Welling, Catherine Fortuné, Catarina Leite, Karen Gottesman, Maureen Sauve, Tatiana Sofía Rodríguez-Reyna, Maggie Larche, Ward van Breda, Maria E. Suarez-Almazor, Amanda Wurz, Nicole Culos-Reed, Vanessa L. Malcarne, Maureen D. Mayes, Isabelle Boutron, Luc Mouthon, Andrea Benedetti, Brett D. Thombs, on behalf of the SPIN Investigators
Published 2021-11-01

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

by Elena López-Isac, Marialbert Acosta-Herrera, Martin Kerick, Shervin Assassi, Ansuman T. Satpathy, Jeffrey Granja, Maxwell R. Mumbach, Lorenzo Beretta, Carmen P. Simeón, Patricia Carreira, Norberto Ortego-Centeno, Ivan Castellvi, Lara Bossini-Castillo, F. David Carmona, Gisela Orozco, Nicolas Hunzelmann, Jörg H. W. Distler, Andre Franke, Claudio Lunardi, Gianluca Moroncini, Armando Gabrielli, Jeska de Vries-Bouwstra, Cisca Wijmenga, Bobby P. C. Koeleman, Annika Nordin, Leonid Padyukov, Anna-Maria Hoffmann-Vold, Benedicte Lie, European Scleroderma Group†, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), Timothy Vyse, Ariane L. Herrick, Jane Worthington, Christopher P. Denton, Yannick Allanore, Matthew A. Brown, Timothy R. D. J. Radstake, Carmen Fonseca, Howard Y. Chang, Maureen D. Mayes, Javier Martin
Published 2019-10-01